ETS2 function is required to maintain the transformed state of human prostate cancer cells (original) (raw)
- Original Paper
- Published: 07 December 1998
Oncogene volume 17, pages 2883–2888 (1998)Cite this article
- 721 Accesses
- 62 Citations
- 6 Altmetric
- Metrics details
Abstract
The contribution of the ETS2 transcription factor to the transformed state in prostate cancer cells has been assessed. Northern blot analysis easily detects ETS2 in DU145 and PC3, high grade human prostate cell lines, but ETS2 is not present in lower grade LNCaP cells. Stable transfection of PC3 and DU145 prostate cell lines with an antisense ETS2 vector or with a dominant negative ETS2 mutant significantly reduced the ability of DU145 and PC3 cells to form large colonies in soft agar. Thus, the presence of ETS2 is positively correlated with a more transformed phenotype and blockage of ETS2 function can reduce transformed properties of prostate cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Center for Molecular and Structural Biology, Hollings Cancer Center, Medical University of South Carolina, 171 Ashley Avenue, Charleston, 29425, South Carolina, USA
Victor I Sementchenko, Clifford W Schweinfest, Takis S Papas & Dennis K Watson
Authors
- Victor I Sementchenko
- Clifford W Schweinfest
- Takis S Papas
- Dennis K Watson
Rights and permissions
About this article
Cite this article
Sementchenko, V., Schweinfest, C., Papas, T. et al. ETS2 function is required to maintain the transformed state of human prostate cancer cells.Oncogene 17, 2883–2888 (1998). https://doi.org/10.1038/sj.onc.1202220
- Received: 22 March 1998
- Revised: 16 June 1998
- Accepted: 16 June 1998
- Published: 07 December 1998
- Issue date: 03 December 1998
- DOI: https://doi.org/10.1038/sj.onc.1202220